As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...